[1]
“The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study”, Reumatismo, vol. 68, no. 4, pp. 188–194, Dec. 2016, doi: 10.4081/reumatismo.2016.903.